ImmunityBio, Inc.
IBRX
$7.77
-$0.29-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.17% | 56.86% | -5.82% | 67.78% | 149.48% |
| Total Receivables | 23.63% | 1.54% | 26.40% | 50.99% | 27.94% |
| Inventory | 254.66% | -39.89% | -86.42% | 0.95% | -21.36% |
| Prepaid Expenses | 38.30% | 12.28% | -11.38% | 19.98% | 16.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -20.10% | -4.65% | 26.86% | 19.90% |
| Total Current Assets | -3.08% | 43.85% | -4.44% | 58.31% | 90.66% |
|
|
|||||
| Total Current Assets | -3.08% | 43.85% | -4.44% | 58.31% | 90.66% |
| Net Property, Plant & Equipment | -0.26% | -1.00% | -9.52% | -2.95% | 0.59% |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.16% | -8.19% | -3.85% | -3.57% | -3.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.86% | 206.83% | 0.71% | 9.76% | -10.22% |
| Total Assets | -2.80% | 28.84% | -3.29% | 29.08% | 32.37% |
|
|
|||||
| Total Accounts Payable | 7.21% | 60.39% | 20.87% | -22.19% | -45.05% |
| Total Accrued Expenses | 24.84% | 6.80% | 6.84% | 16.04% | 32.44% |
| Short-term Debt | -- | -49.51% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.51% | 1.21% | 3.00% | -1.01% | -0.25% |
| Total Finance Division Other Current Liabilities | -65.46% | -2.83% | -26.68% | 146.44% | -28.65% |
| Total Other Current Liabilities | -65.46% | -2.83% | -26.68% | 146.44% | -28.65% |
| Total Current Liabilities | 12.91% | 10.04% | 8.09% | 12.81% | 2.92% |
|
|
|||||
| Total Current Liabilities | 12.91% | 10.04% | 8.09% | 12.81% | 2.92% |
| Long-Term Debt | 9.86% | 35.05% | -1.87% | 2.23% | 2.19% |
| Short-term Debt | -- | -49.51% | -- | -- | -- |
| Capital Leases | -5.87% | -0.93% | -2.03% | -4.77% | 9.05% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.54% | 217.98% | -22.10% | 55.70% | 187.37% |
| Total Liabilities | 10.46% | 51.35% | -3.93% | 7.25% | 8.68% |
|
|
|||||
| Common Stock & APIC | 1.56% | 8.28% | 1.97% | 4.02% | 4.17% |
| Retained Earnings | -5.28% | -16.98% | -1.69% | -1.87% | -2.64% |
| Treasury Stock & Other | -0.62% | -5.19% | 479.47% | -60.24% | -37.02% |
| Total Common Equity | -20.30% | -73.84% | 4.55% | 8.13% | 3.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.30% | -73.84% | 4.55% | 8.13% | 3.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.36% | -1.68% | -1.54% | -2.26% | -2.00% |
| Total Equity | -20.32% | -73.97% | 4.55% | 8.14% | 3.50% |
|
|
|||||